Medical News

RSS

Spread of cancer in melanoma patients can be determined by ultrasound signals

Researchers have shown for the first time that patterns of ultrasound signals can be used to identify whether or not cancer has started to spread in melanoma patients, and to what extent. The discovery enables doctors to decide on how much surgery, if any, is required and to predict the patient's probable survival.

23 Sep 2009

FDA warns: Personal emergency response buttons are a potential choking hazard

The U.S. Food and Drug Administration today cautioned users of personal emergency response buttons worn around the neck of a potential choking hazard associated with this product.

23 Sep 2009

Findings of 2009 Project Resource Management Survey released

Cognitive Technologies – a consulting firm specializing in project management, collaborative processes, and organizational effectiveness for the federal government and Fortune 1000 companies – today released the findings of its 2009 Project Resource Management Survey®, which reveals how resource management tools and processes are being used in organizations across the United States.

23 Sep 2009

St. Jude Medical's cardiovascular healthcare portfolio to be presented at TCT meeting

St. Jude Medical, Inc. (NYSE:STJ) today announced it will display products and technologies from the company’s portfolio of solutions for cardiovascular healthcare professionals at the 21st annual Transcatheter Cardiovascular Therapeutics meeting in San Francisco. The featured products reflect the company’s continued commitment to developing comprehensive, high-performance solutions which advance the practice of interventional cardiology by improving efficiencies and giving physicians more control.

23 Sep 2009

Pathway Medical's Jetstream G2 NXT catheter boosts its growth by 172 percent over the last two quarters

Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral vascular disease (PVD), today announced a 172 percent growth over the last two quarters with its Jetstream peripheral revascularization catheters at more than 150 centers of excellence in the United States.

23 Sep 2009

Drugs blocking the effects of ACh may prevent cancer

By seeing what substances and molecules affect the development of our diseases, we can develop drugs that prevent or cure diseases. In her dissertation at Kalmar University in Sweden, Ann Novotny has found that the signal molecule acetylcholine (ACh) is important for the progress of cancer of the large intestine and colon, knowledge that is important to factor in when developing drugs that block the effects of Ach on tumor cells.

23 Sep 2009

Revolution Medical's MRI software suit to be launched at RSNA annual meeting

Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB: RMCP), producers of the Rev Vac safety syringe, today announced that it will debut its evolutionary MRI software suite at the Radiological Society of North America (RSNA) annual meeting at McCormick Place in Chicago on November 29th - December 4th.

23 Sep 2009

NCPA supports proposal for adopting PBM transparency

The National Community Pharmacists Association (NCPA) today praised U.S. Sen. Maria Cantwell (D-WA) for authoring an amendment to lower health care costs by adopting common-sense disclosure requirements for any pharmacy benefit manager (PBM) participating in the health insurance exchanges envisioned under a proposal by Sen. Max Baucus (D-MT).

23 Sep 2009

Genous Bio-engineered R stent for STEMI implantation exhibits safety

OrbusNeich announced today that interim data from a prospective registry showed good safety in a broad population of patients that underwent primary percutaneous coronary intervention (PCI) and implantation of the company's Genous Bio-engineered R stent for ST-elevation myocardial infarction (STEMI).

23 Sep 2009

New method to identify active tuberculosis in patients

Active tuberculosis can be rapidly identified in patients with negative sputum tests by a new method, according to European researchers. Active tuberculosis (TB) is the seventh-leading cause of death worldwide, and while the diagnosis of active TB can be rapidly established when the bacteria can be identified on sputum microscopy, in about half of all cases, the TB bacterium cannot be detected, making another diagnostic option critical in efforts to control the spread of TB.

23 Sep 2009

Survey reveals surgery residents concerned with motivations to pursue surgical careers

A survey of nearly 4,500 general surgery residents finds that the majority are satisfied with their training and relationships with faculty and peers, but also indicated concerns regarding motivations for pursuing surgical careers and the need to complete specialty training, according to a study in the September 23/30 issue of JAMA, a theme issue on medical education.

23 Sep 2009

Small business leader say affordability is key to health reform

NPR reports: "Under various health care overhaul bills on Capitol Hill, small-business owners would be required to insure themselves. Amanda Austin, director of federal public policy for the National Federation of Independent Business, says affordability is the key if the government mandates health coverage."

23 Sep 2009

MMI to provide sign language interpreters for deaf or hard-of-hearing patients

Under a voluntary resolution agreement reached with the U.S. Department of Health and Human Services (HHS), deaf or hard-of-hearing patients at the Mid-Maryland Musculoskeletal Institute (MMI) of Frederick, Md., will be screened and provided with sign language interpreters whenever interpreter services are necessary for effective communication. MMI is an 11-physician orthopedic practice with offices in Frederick and Hagerstown, Md., serving approximately 1,000 patients per month.

23 Sep 2009

Institutional investors offer 50 million for Spectrum Pharmaceuticals

Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a focus primarily in oncology, today announced that it has received $50 million from existing institutional investors in a previously announced registered direct offering.

23 Sep 2009

Breakthrough in the successful treatment of AMI

Medical device pioneer Stentys announced today the results on 20 patients participating in the Company’s ‘APPOSITION I’ clinical study—the world’s first to treat patients with acute myocardial infarction (AMI) via a self-expanding stent. These data were disclosed today by the study’s principal investigator, Christian Spaulding, M.D., Ph.D., to an audience of cardiologists during a Stentys-hosted satellite meeting at the Transcatheter Cardiovascular Therapeutics (“TCT”) 2009 annual scientific meeting.

23 Sep 2009

Bioscreen Instruments to be Labcyte's partner in India

Labcyte, the developer of acoustic liquid transfer, with systems in all top 10 pharmaceutical companies, today announced the selection of Bioscreen Instruments Pvt. Ltd. as its exclusive distributor in India.

23 Sep 2009

Pfizer in 2009 Working Mother 100 Best Companies list

Pfizer Inc has been named among the 2009 Working Mother 100 Best Companies for its steadfast commitment to family-friendly benefits. Pfizer and the other winning companies are pioneering programs that support families, with 100 percent offering flextime, on-site lactation and telecommuting; and 98 percent offering job-sharing and wellness programs—numbers that dwarf those seen nationwide. In addition, financial programs available to the 100 Best employees are on the rise, a much needed boost for families in today’s economy.

23 Sep 2009

Inverness Medical Innovations to raise funds for acquisition of Free & Clear

Inverness Medical Innovations, Inc. (NYSE: IMA) announced today that it intends to offer $100 million of senior notes due 2016 through a private placement, subject to market and other conditions. Inverness intends to use the net proceeds from the offering solely to fund its previous announced acquisition of Free & Clear, Inc.

23 Sep 2009

Pros and cons of the estimated Glomerular Filtration Rate

As many as 26 million Americans live with chronic kidney disease (CKD) and according to the National Institutes of Health (NIH), at least 10.4 million (or 40%) don't even know they have it. Enter the estimated Glomerular Filtration Rate (eGFR), which has become the preferred method for identifying people with CKD.

23 Sep 2009

Fourth-quarter and fiscal year end 2009 results announced by Natural Alternatives International

Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a net loss of $4.1 million or $0.58 per diluted share on net sales from continuing operations of $73.9 million for the fiscal year ended June 30, 2009.

23 Sep 2009